These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29141886)

  • 1. PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes.
    Ben Nasr M; Tezza S; D'Addio F; Mameli C; Usuelli V; Maestroni A; Corradi D; Belletti S; Albarello L; Becchi G; Fadini GP; Schuetz C; Markmann J; Wasserfall C; Zon L; Zuccotti GV; Fiorina P
    Sci Transl Med; 2017 Nov; 9(416):. PubMed ID: 29141886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered PD-L1-Expressing Platelets Reverse New-Onset Type 1 Diabetes.
    Zhang X; Kang Y; Wang J; Yan J; Chen Q; Cheng H; Huang P; Gu Z
    Adv Mater; 2020 Jul; 32(26):e1907692. PubMed ID: 32449212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B lymphocytes expressing high levels of PD-L1 are key regulators of diabetes development in non-obese diabetic mice.
    Chen K; Xue Q; Liu F; Liu L; Yu C; Bian G; Zhang K; Fang C; Song J; Ju G; Wang J
    Mol Immunol; 2019 Oct; 114():289-298. PubMed ID: 31419705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E2 Stimulates the Expansion of Regulatory Hematopoietic Stem and Progenitor Cells in Type 1 Diabetes.
    Ben Nasr M; D'Addio F; Malvandi AM; Faravelli S; Castillo-Leon E; Usuelli V; Rocchio F; Letizia T; El Essawy AB; Assi E; Mameli C; Giani E; Macedoni M; Maestroni A; Dassano A; Loretelli C; Paroni M; Cannalire G; Biasucci G; Sala M; Biffi A; Zuccotti GV; Fiorina P
    Front Immunol; 2018; 9():1387. PubMed ID: 29971065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioengineered Artificial Extracellular Vesicles Presenting PD-L1 and Gal-9 Ameliorate New-Onset Type 1 Diabetes.
    Yang Z; Zhang Z; Li L; Jing Z; Ma Y; Lan T; Li Y; Lin Z; Fang W; Zhang J; Zhang J; Liang X; Wu B; Zheng Y; Zhang X
    Diabetes; 2024 Aug; 73(8):1325-1335. PubMed ID: 38771941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-L1-driven tolerance protects neurogenin3-induced islet neogenesis to reverse established type 1 diabetes in NOD mice.
    Li R; Lee J; Kim MS; Liu V; Moulik M; Li H; Yi Q; Xie A; Chen W; Yang L; Li Y; Tsai TH; Oka K; Chan L; Yechoor V
    Diabetes; 2015 Feb; 64(2):529-40. PubMed ID: 25332429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue expression of PD-L1 mediates peripheral T cell tolerance.
    Keir ME; Liang SC; Guleria I; Latchman YE; Qipo A; Albacker LA; Koulmanda M; Freeman GJ; Sayegh MH; Sharpe AH
    J Exp Med; 2006 Apr; 203(4):883-95. PubMed ID: 16606670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy.
    Tian C; Ansari MJ; Paez-Cortez J; Bagley J; Godwin J; Donnarumma M; Sayegh MH; Iacomini J
    J Immunol; 2007 Nov; 179(10):6762-9. PubMed ID: 17982066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade.
    Kawada-Horitani E; Kita S; Okita T; Nakamura Y; Nishida H; Honma Y; Fukuda S; Tsugawa-Shimizu Y; Kozawa J; Sakaue T; Kawachi Y; Fujishima Y; Nishizawa H; Azuma M; Maeda N; Shimomura I
    Diabetologia; 2022 Jul; 65(7):1185-1197. PubMed ID: 35511238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the PD-1/PD-L1 Dyad in the Maintenance of Pancreatic Immune Tolerance for Prevention of Type 1 Diabetes.
    Falcone M; Fousteri G
    Front Endocrinol (Lausanne); 2020; 11():569. PubMed ID: 32973682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic
    Li C; Course MM; McNeish IA; Drescher CW; Valdmanis PN; Lieber A
    Cancer Res; 2020 Feb; 80(3):549-560. PubMed ID: 31727629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human stem cell derived beta-like cells engineered to present PD-L1 improve transplant survival in NOD mice carrying human HLA class I.
    Santini-González J; Castro-Gutierrez R; Becker MW; Rancourt C; Russ HA; Phelps EA
    Front Endocrinol (Lausanne); 2022; 13():989815. PubMed ID: 36506044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-1, but not PD-L1, expressed by islet-reactive CD4+ T cells suppresses infiltration of the pancreas during type 1 diabetes.
    Pauken KE; Jenkins MK; Azuma M; Fife BT
    Diabetes; 2013 Aug; 62(8):2859-69. PubMed ID: 23545706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stat5b/Ezh2 axis governs high PD-L1 expressing tolerogenic dendritic cell subset in autoimmune diabetes.
    Ullah Khan F; Khongorzul P; Gris D; Amrani A
    Int Immunopharmacol; 2024 May; 133():112166. PubMed ID: 38678673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective role of programmed death 1 ligand 1 (PD-L1)in nonobese diabetic mice: the paradox in transgenic models.
    Wang CJ; Chou FC; Chu CH; Wu JC; Lin SH; Chang DM; Sytwu HK
    Diabetes; 2008 Jul; 57(7):1861-9. PubMed ID: 18420489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of peripheral blood mononuclear cell-derived humanized lung cancer mouse models for studying efficacy of PD-L1/PD-1 targeted immunotherapy.
    Lin S; Huang G; Cheng L; Li Z; Xiao Y; Deng Q; Jiang Y; Li B; Lin S; Wang S; Wu Q; Yao H; Cao S; Li Y; Liu P; Wei W; Pei D; Yao Y; Wen Z; Zhang X; Wu Y; Zhang Z; Cui S; Sun X; Qian X; Li P
    MAbs; 2018; 10(8):1301-1311. PubMed ID: 30204048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo.
    Paterson AM; Brown KE; Keir ME; Vanguri VK; Riella LV; Chandraker A; Sayegh MH; Blazar BR; Freeman GJ; Sharpe AH
    J Immunol; 2011 Aug; 187(3):1097-105. PubMed ID: 21697456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory Cell Infiltration Into Islets Without PD-L1 Expression Is Associated With the Development of Immune Checkpoint Inhibitor-Related Type 1 Diabetes in Genetically Susceptible Patients.
    Kawata S; Kozawa J; Yoneda S; Fujita Y; Kashiwagi-Takayama R; Kimura T; Hosokawa Y; Baden MY; Uno S; Uenaka R; Namai K; Koh Y; Tomimaru Y; Hirata H; Uemura M; Nojima S; Morii E; Eguchi H; Imagawa A; Shimomura I
    Diabetes; 2023 Apr; 72(4):511-519. PubMed ID: 36657987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maturation of hematopoietic stem cells from prehematopoietic stem cells is accompanied by up-regulation of PD-L1.
    Tober J; Maijenburg MMW; Li Y; Gao L; Hadland BK; Gao P; Minoura K; Bernstein ID; Tan K; Speck NA
    J Exp Med; 2018 Feb; 215(2):645-659. PubMed ID: 29282253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC-mismatched mixed chimerism restores peripheral tolerance of noncross-reactive autoreactive T cells in NOD mice.
    Zhang M; Racine JJ; Lin Q; Liu Y; Tang S; Qin Q; Qi T; Riggs AD; Zeng D
    Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2329-E2337. PubMed ID: 29463744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.